7967 related articles for article (PubMed ID: 2448252)
1. Mouse monoclonal antibodies detecting disialogangliosides on mouse and human T lymphomas.
Kawashima I; Tada N; Ikegami S; Nakamura S; Ueda R; Tai T
Int J Cancer; 1988 Feb; 41(2):267-74. PubMed ID: 2448252
[TBL] [Abstract][Full Text] [Related]
2. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2.
Tai T; Kawashima I; Tada N; Dairiki K
J Biochem; 1988 Apr; 103(4):682-7. PubMed ID: 3170507
[TBL] [Abstract][Full Text] [Related]
3. Two human monoclonal antibodies reacting with the major gangliosides of human melanomas and comparison with corresponding mouse monoclonal antibodies.
Furukawa K; Yamaguchi H; Oettgen HF; Old LJ; Lloyd KO
Cancer Res; 1989 Jan; 49(1):191-6. PubMed ID: 2908845
[TBL] [Abstract][Full Text] [Related]
4. Production of monoclonal antibodies specific for ganglioside GD3.
Watarai S; Onuma M; Yasuda T
J Biochem; 1991 Dec; 110(6):889-95. PubMed ID: 1724444
[TBL] [Abstract][Full Text] [Related]
5. Generation of monoclonal antibodies specific for ganglioside lactones: evidence of the expression of lactone on human melanoma cells.
Kawashima I; Kotani M; Ozawa H; Suzuki M; Tai T
Int J Cancer; 1994 Jul; 58(2):263-8. PubMed ID: 8026889
[TBL] [Abstract][Full Text] [Related]
6. GD2 oligosaccharide: target for cytotoxic T lymphocytes.
Zhao XJ; Cheung NK
J Exp Med; 1995 Jul; 182(1):67-74. PubMed ID: 7540657
[TBL] [Abstract][Full Text] [Related]
7. Immunorecognition of ganglioside epitopes: correlation between affinity and cytotoxicity of ganglioside antibodies.
Dippold W; Bernhard H
Eur J Cancer; 1992; 28A(10):1605-10. PubMed ID: 1382491
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody Leo Mel 3, which inhibits killing of human melanoma cells by anomalous killer cells, binds to a sugar sequence in GD2 (II3(NeuAc)2-GgOse3Cer) and several other gangliosides.
Fukuta S; Werkmeister JA; Burns GF; Ginsburg V; Magnani JL
J Biol Chem; 1987 Apr; 262(10):4800-3. PubMed ID: 2435716
[TBL] [Abstract][Full Text] [Related]
9. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity.
Thurin J; Thurin M; Kimoto Y; Herlyn M; Lubeck MD; Elder DE; Smereczynska M; Karlsson KA; Clark WM; Steplewski Z
Cancer Res; 1987 Mar; 47(5):1229-33. PubMed ID: 3815333
[TBL] [Abstract][Full Text] [Related]
11. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
Ravindranath MH; Morton DL; Irie RF
Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a human melanoma-associated ganglioside antigen defined by a monoclonal antibody, 4.2.
Nudelman E; Hakomori S; Kannagi R; Levery S; Yeh MY; Hellström KE; Hellström I
J Biol Chem; 1982 Nov; 257(21):12752-6. PubMed ID: 7130176
[TBL] [Abstract][Full Text] [Related]
13. Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside.
Brodin T; Hellström I; Hellström KE; Karlsson KA; Sjögren HO; Strömberg N; Thurin J
Biochim Biophys Acta; 1985 Dec; 837(3):349-53. PubMed ID: 3840699
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
Kawashima I; Tada N; Fujimori T; Tai T
J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
[TBL] [Abstract][Full Text] [Related]
15. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins.
Cheresh DA; Pierschbacher MD; Herzig MA; Mujoo K
J Cell Biol; 1986 Mar; 102(3):688-96. PubMed ID: 3005335
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas.
Hirabayashi Y; Higashi H; Kato S; Taniguchi M; Matsumoto M
Jpn J Cancer Res; 1987 Jun; 78(6):614-20. PubMed ID: 3112076
[TBL] [Abstract][Full Text] [Related]
17. Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.
Cahan LD; Irie RF; Singh R; Cassidenti A; Paulson JC
Proc Natl Acad Sci U S A; 1982 Dec; 79(24):7629-33. PubMed ID: 6296843
[TBL] [Abstract][Full Text] [Related]
18. Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma.
Hirabayashi Y; Hamaoka A; Matsumoto M; Matsubara T; Tagawa M; Wakabayashi S; Taniguchi M
J Biol Chem; 1985 Oct; 260(24):13328-33. PubMed ID: 2414279
[TBL] [Abstract][Full Text] [Related]
19. Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.
Cheung NK; Canete A; Cheung IY; Ye JN; Liu C
Int J Cancer; 1993 May; 54(3):499-505. PubMed ID: 8509225
[TBL] [Abstract][Full Text] [Related]
20. Expression of GD3 disialoganglioside antigen on peripheral T-lymphocytes in patients with disseminated malignant melanoma.
Welte B; Handgretinger R; Rassner G; Fierlbeck G
Exp Dermatol; 1997 Apr; 6(2):64-9. PubMed ID: 9209886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]